Crossmark

Integrated Bioinformatics Analysis and Transcriptomics Analysis Predict Jumonji and AT Rich Interacting Domain2 (JARID2) as a Therapeutic Target in Human Cancers

Crossref DOI link: https://doi.org/10.52756/ijerr.2024.v39spl.002

Published Online: 2024-05-30

Update policy: https://doi.org/10.52756/iaphcrossmarkpolicy

Authors

Sreeshma, Bhuvanadas http://orcid.org/0000-0002-7645-889X
Mohideen, Habeeb Shaik http://orcid.org/0000-0003-4217-5063
Devi, Arikketh http://orcid.org/0000-0002-8542-3760
License Information

License valid from 2024-05-30
More Information

Content Type: Research Article

CrossChecked: Yes

Peer Reviewed: Yes

Published: 2024-05-30

Rights

License: Creative Commons Attribution

Document is current

Any future updates will be listed below